NasdaqCM - Delayed Quote USD

Corcept Therapeutics Incorporated (CORT)

22.80 +0.59 (+2.66%)
At close: April 26 at 4:00 PM EDT
21.90 -0.90 (-3.95%)
After hours: April 26 at 7:33 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
482,375.00
482,375.00
401,858.00
365,978.00
353,874.00
Cost of Revenue
6,481.00
6,481.00
5,385.00
5,281.00
5,582.00
Gross Profit
475,894.00
475,894.00
396,473.00
360,697.00
348,292.00
Operating Expense
368,612.00
368,612.00
283,839.00
236,220.00
220,090.00
Operating Income
107,282.00
107,282.00
112,634.00
124,477.00
128,202.00
Net Non Operating Interest Income Expense
17,275.00
17,275.00
3,557.00
529.00
3,400.00
Pretax Income
124,557.00
124,557.00
116,191.00
125,006.00
131,602.00
Tax Provision
18,417.00
18,417.00
14,773.00
12,494.00
25,591.00
Net Income Common Stockholders
105,496.00
105,496.00
101,288.00
112,512.00
106,011.00
Diluted NI Available to Com Stockholders
105,496.00
105,496.00
101,288.00
112,512.00
106,011.00
Basic EPS
0.87
1.02
0.95
0.97
0.92
Diluted EPS
0.80
0.94
0.87
0.89
0.85
Basic Average Shares
104,877.50
103,560.00
106,787.00
115,653.00
115,412.00
Diluted Average Shares
113,143.00
111,742.00
115,966.00
125,963.00
124,194.00
Total Operating Income as Reported
107,282.00
107,282.00
112,634.00
124,477.00
128,202.00
Total Expenses
375,093.00
375,093.00
289,224.00
241,501.00
225,672.00
Net Income from Continuing & Discontinued Operation
106,140.00
106,140.00
101,418.00
112,512.00
106,011.00
Normalized Income
106,140.00
106,140.00
101,418.00
112,512.00
106,011.00
Interest Income
17,275.00
17,275.00
3,557.00
529.00
3,400.00
Net Interest Income
17,275.00
17,275.00
3,557.00
529.00
3,400.00
EBIT
107,282.00
107,282.00
112,634.00
124,477.00
128,202.00
EBITDA
109,644.00
109,644.00
116,080.00
127,953.00
130,439.00
Reconciled Cost of Revenue
6,481.00
6,481.00
5,385.00
5,281.00
5,582.00
Reconciled Depreciation
2,362.00
2,362.00
3,446.00
3,476.00
2,237.00
Net Income from Continuing Operation Net Minority Interest
106,140.00
106,140.00
101,418.00
112,512.00
106,011.00
Normalized EBITDA
109,644.00
109,644.00
116,080.00
127,953.00
130,439.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 4/14/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CYTK Cytokinetics, Incorporated
65.34
+0.83%
 
IMVT Immunovant, Inc.
27.17
-2.09%
 
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
 
JANX Janux Therapeutics, Inc.
47.39
+0.62%
 
BPMC Blueprint Medicines Corporation
93.00
+2.50%
 
KURA Kura Oncology, Inc.
19.65
+3.42%
 
BBIO BridgeBio Pharma, Inc.
24.88
+2.26%
 
APLS Apellis Pharmaceuticals, Inc.
49.86
+4.03%
 
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
 
MRUS Merus N.V.
45.04
+0.24%